{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:18:28Z","timestamp":1793438308950,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NCI","award":["P30CA125123"],"award-info":[{"award-number":["P30CA125123"]}]},{"DOI":"10.13039\/100004917","name":"CPRIT","doi-asserted-by":"crossref","award":["RP200504"],"award-info":[{"award-number":["RP200504"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH\/NIEHS","award":["P42 ES027725"],"award-info":[{"award-number":["P42 ES027725"]}]},{"DOI":"10.13039\/100006545","name":"NIMHD","doi-asserted-by":"crossref","award":["P50MD015496"],"award-info":[{"award-number":["P50MD015496"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["T32CA96520"],"award-info":[{"award-number":["T32CA96520"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"MacDonald Research Fund","award":["20RDM004"],"award-info":[{"award-number":["20RDM004"]}]},{"name":"JLH Foundation Award","award":["55354"],"award-info":[{"award-number":["55354"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The clinical use of circulating biomarkers for primary graft dysfunction (PGD) after lung transplantation has been limited. In a prospective single-center cohort, we examined the use of plasma protein biomarkers as indicators of PGD severity and duration after lung transplantation. The study comprised 40 consecutive lung transplant patients who consented to blood sample collection immediately pretransplant and at 6, 24, 48, and 72\u00a0h after lung transplant. An expert grader determined the severity and duration of PGD and scored PGD at T0 (6\u00a0h after reperfusion), T24, T48, and T72 h post-reperfusion using the 2016 ISHLT consensus guidelines. A bead-based multiplex assay was used to measure 27 plasma proteins including cytokines, growth factors, and chemokines. Enzyme-linked immunoassay was used to measure cell injury markers including M30, M65, soluble receptor of advanced glycation end-products (sRAGE), and plasminogen activator inhibitor-1 (PAI-1). A pairwise comparisons analysis was used to assess differences in protein levels between PGD severity scores (1, 2, and 3) at T0, T24, T48, and T72 h. Sensitivity and temporal analyses were used to explore the association of protein expression patterns and PGD3 at T48\u201372\u00a0h (the most severe, persistent form of PGD). We used the Benjamini\u2013Hochberg method to adjust for multiple testing. Of the 40 patients, 22 (55%) had PGD3 at some point post-transplant from T0 to T72 h; 12 (30%) had PGD3 at T48\u201372\u00a0h. In the pairwise comparison, we identified a robust plasma protein expression signature for PGD severity. In the sensitivity analysis, using a linear model for microarray data, we found that differential perioperative expression of IP-10, MIP1B, RANTES, IL-8, IL-1Ra, G-CSF, and PDGF-BB correlated with PGD3 development at T48\u201372\u00a0h (FDR\u2009&lt;\u20090.1 and\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). In the temporal analysis, using linear mixed modeling with overlap weighting, we identified unique protein patterns in patients who did or did not develop PGD3 at T48\u201372\u00a0h. Our findings suggest that unique inflammatory protein expression patterns may be informative of PGD severity and duration. PGD biomarker panels may improve early detection of PGD, predict its clinical course, and help monitor treatment efficacy in the current era of lung transplantation.\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-20085-y","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T15:11:58Z","timestamp":1664291518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Plasma protein biomarkers for primary graft dysfunction after lung transplantation: a single-center cohort analysis"],"prefix":"10.1038","volume":"12","author":[{"given":"Lourdes","family":"Chacon-Alberty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupa S.","family":"Kanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengbin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Hochman-Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoud","family":"Daoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Coarfa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maher","family":"Baz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Loor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"key":"20085_CR1","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.healun.2017.07.013","volume":"36","author":"D Van Raemdonck","year":"2017","unstructured":"Van Raemdonck, D. et al. Report of the ISHLT Working Group on primary lung graft dysfunction part IV: Prevention and treatment: A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation. J. Heart Lung Transplant. 36, 1121\u20131136 (2017).","journal-title":"J. Heart Lung Transplant."},{"key":"20085_CR2","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ccm.2017.07.005","volume":"38","author":"MK Porteous","year":"2017","unstructured":"Porteous, M. K. & Lee, J. C. Primary graft dysfunction after lung transplantation. Clin. Chest Med. 38, 641\u2013654 (2017).","journal-title":"Clin. Chest Med."},{"key":"20085_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1164\/rccm.201706-1140OC","volume":"197","author":"E Cantu","year":"2018","unstructured":"Cantu, E. et al. Quantitative evidence for revising the definition of primary graft dysfunction after lung transplant. Am. J. Respir. Crit. Care Med. 197, 235\u2013243 (2018).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"20085_CR4","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.healun.2017.07.021","volume":"36","author":"GI Snell","year":"2017","unstructured":"Snell, G. I. et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, part I: Definition and grading-A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation. J. Heart Lung Transplant. 36, 1097\u20131103 (2017).","journal-title":"J. Heart Lung Transplant."},{"key":"20085_CR5","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.21037\/jtd-20-3564","volume":"13","author":"D Daoud","year":"2021","unstructured":"Daoud, D. et al. Incidence of primary graft dysfunction is higher according to the new ISHLT 2016 guidelines and correlates with clinical and molecular risk factors. J. Thorac. Dis. 13, 3426\u20133442 (2021).","journal-title":"J. Thorac. Dis."},{"key":"20085_CR6","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1378\/chest.113.3.645","volume":"113","author":"H Mal","year":"1998","unstructured":"Mal, H. et al. Early release of proinflammatory cytokines after lung transplantation. Chest 113, 645\u2013651 (1998).","journal-title":"Chest"},{"key":"20085_CR7","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1067\/mtc.2001.113603","volume":"121","author":"SM Fiser","year":"2001","unstructured":"Fiser, S. M. et al. Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response. J. Thorac. Cardiovasc. Surg. 121, 1069\u20131075 (2001).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"20085_CR8","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1164\/rccm.200901-0118OC","volume":"180","author":"JD Christie","year":"2009","unstructured":"Christie, J. D. et al. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am. J. Respir. Crit. Care Med. 180, 1010\u20131015 (2009).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"20085_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.surg.2009.02.011","volume":"146","author":"VE Laubach","year":"2009","unstructured":"Laubach, V. E. & Kron, I. L. Pulmonary inflammation after lung transplantation. Surgery 146, 1\u20134 (2009).","journal-title":"Surgery"},{"key":"20085_CR10","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.4049\/jimmunol.1301539","volume":"191","author":"H Shen","year":"2013","unstructured":"Shen, H., Kreisel, D. & Goldstein, D. R. Processes of sterile inflammation. J. Immunol. 191, 2857\u20132863 (2013).","journal-title":"J. Immunol."},{"key":"20085_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1164\/rccm.201510-2115OC","volume":"194","author":"K Hashimoto","year":"2016","unstructured":"Hashimoto, K. et al. Circulating cell death biomarkers may predict survival in human lung transplantation. Am. J. Respir. Crit. Care Med. 194, 97\u2013105 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"20085_CR12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.healun.2017.06.005","volume":"37","author":"K Hashimoto","year":"2017","unstructured":"Hashimoto, K. et al. Higher M30 and high mobility group box 1 protein levels in ex vivo lung perfusate are associated with primary graft dysfunction after human lung transplantation. J. Heart Lung Transplant. 37, 240 (2017).","journal-title":"J. Heart Lung Transplant."},{"key":"20085_CR13","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.healun.2017.07.014","volume":"36","author":"AE Gelman","year":"2017","unstructured":"Gelman, A. E. et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part III: Mechanisms: A 2016 Consensus Group Statement of the International Society for Heart and Lung Transplantation. J. Heart Lung Transplant. 36, 1114\u20131120 (2017).","journal-title":"J. Heart Lung Transplant."},{"key":"20085_CR14","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/j.athoracsur.2005.11.053","volume":"81","author":"A Mathur","year":"2006","unstructured":"Mathur, A. et al. Cytokine profile after lung transplantation: Correlation with allograft injury. Ann. Thorac. Surg. 81, 1844\u20131849 (2006).","journal-title":"Ann. Thorac. Surg."},{"key":"20085_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1600-6143.2008.02497.x","volume":"9","author":"SA Hoffman","year":"2009","unstructured":"Hoffman, S. A. et al. Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Am. J. Transplant. 9, 389\u2013396 (2009).","journal-title":"Am. J. Transplant."},{"key":"20085_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1164\/rccm.200606-827OC","volume":"175","author":"JD Christie","year":"2007","unstructured":"Christie, J. D. et al. Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction. Am. J. Respir. Crit. Care Med. 175, 69\u201374 (2007).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"20085_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.trsl.2012.08.003","volume":"160","author":"RJ Shah","year":"2012","unstructured":"Shah, R. J. et al. Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation. Transl. Res. 160, 435\u2013442 (2012).","journal-title":"Transl. Res."},{"key":"20085_CR18","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"20085_CR19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Stat. Methodol. 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B Stat. Methodol."},{"key":"20085_CR20","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1080\/01621459.2016.1260466","volume":"113","author":"F Li","year":"2018","unstructured":"Li, F., Morgan, K. L. & Zaslavsky, A. M. Balancing covariates via propensity score weighting. J. Am. Stat. Assoc. 113, 390\u2013400 (2018).","journal-title":"J. Am. Stat. Assoc."},{"key":"20085_CR21","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1001\/jama.2020.7819","volume":"323","author":"LE Thomas","year":"2020","unstructured":"Thomas, L. E., Li, F. & Pencina, M. J. Overlap weighting: A propensity score method that mimics attributes of a randomized clinical trial. JAMA 323, 2417\u20132418 (2020).","journal-title":"JAMA"},{"key":"20085_CR22","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1177\/0962280219870836","volume":"29","author":"J Dong","year":"2020","unstructured":"Dong, J., Zhang, J. L., Zeng, S. & Li, F. Subgroup balancing propensity score. Stat. Methods Med. Res. 29, 659\u2013676 (2020).","journal-title":"Stat. Methods Med. Res."},{"key":"20085_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00408-017-0001-x","volume":"195","author":"L Rancan","year":"2017","unstructured":"Rancan, L. et al. Chemokine involvement in lung injury secondary to ischaemia\/reperfusion. Lung 195, 333\u2013340 (2017).","journal-title":"Lung"},{"key":"20085_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1164\/rccm.201210-1865OC","volume":"187","author":"JM Diamond","year":"2013","unstructured":"Diamond, J. M. et al. Clinical risk factors for primary graft dysfunction after lung transplantation. Am. J. Respir. Crit. Care Med. 187, 527\u2013534 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"20085_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2021.10.076","author":"G Loor","year":"2022","unstructured":"Loor, G. et al. Effect of mode of intraoperative support on primary graft dysfunction after lung transplant. J. Thorac. Cardiovasc. Surg. https:\/\/doi.org\/10.1016\/j.jtcvs.2021.10.076 (2022).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"20085_CR26","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jtcvs.2019.10.155","volume":"160","author":"K Hoetzenecker","year":"2020","unstructured":"Hoetzenecker, K. et al. Bilateral lung transplantation on intraoperative extracorporeal membrane oxygenator: An observational study. J. Thorac. Cardiovasc. Surg. 160, 320\u2013327 (2020).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"20085_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/j.semtcvs.2018.05.005","volume":"31","author":"G Loor","year":"2019","unstructured":"Loor, G. EVLP: Ready for prime time? Semin. Thorac. Cardiovasc. Surg. 31, 1\u20136 (2019).","journal-title":"Semin. Thorac. Cardiovasc. Surg."},{"key":"20085_CR28","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/MCO.0b013e32833cf3bc","volume":"13","author":"X Zhou","year":"2010","unstructured":"Zhou, X., Fragala, M. S., McElhaney, J. E. & Kuchel, G. A. Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research. Curr. Opin. Clin. Nutr. Metab. Care 13, 541\u2013547 (2010).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"20085_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1161\/CIRCRESAHA.116.304710","volume":"116","author":"RC Schutt","year":"2015","unstructured":"Schutt, R. C. et al. Bone marrow characteristics associated with changes in infarct size after STEMI: A biorepository evaluation from the CCTRN TIME trial. Circ. Res. 116, 99\u2013107 (2015).","journal-title":"Circ. Res."},{"key":"20085_CR30","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41569-020-0381-0","volume":"17","author":"JP Goetze","year":"2020","unstructured":"Goetze, J. P. et al. Cardiac natriuretic peptides. Nat. Rev. Cardiol. 17, 698\u2013717 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"20085_CR31","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","volume":"27","author":"M Wang","year":"2021","unstructured":"Wang, M., Herbst, R. S. & Boshoff, C. Toward personalized treatment approaches for non-small-cell lung cancer. Nat. Med. 27, 1345\u20131356 (2021).","journal-title":"Nat. Med."},{"key":"20085_CR32","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrcardio.2017.48","volume":"14","author":"D Westermann","year":"2017","unstructured":"Westermann, D., Neumann, J. T., Sorensen, N. A. & Blankenberg, S. High-sensitivity assays for troponin in patients with cardiac disease. Nat. Rev. Cardiol. 14, 472\u2013483 (2017).","journal-title":"Nat. Rev. Cardiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20085-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20085-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20085-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T15:55:18Z","timestamp":1728057318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20085-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["20085"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-20085-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]},"assertion":[{"value":"15 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"GL receives institutional Grant support from Transmedics, Abbot, Medtronic, Getinge, St. Jude, and is a consultant for Abiomed. No other authors have any competing interests to report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16137"}}